Although a few reports demonstrate that S100P overexpression may play an oncogenic role in GC, namely by promoting survival and increasing drug resistance of tumour cells [33, 34], conflicting results have also been reported highlighting a putative role of S100P in contributing to sensitization of GC cells to oxaliplatin [35]. The gene discussed is S100P; the disease is neoplasm.